Discontinued — last reported Q3 '23
Intangible assets — net
Biogen Intangible assets — net decreased by 1.7% to $7.25B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.7%, from $7.78B to $7.25B. Over 5 years (FY 2020 to FY 2025), Intangible assets — net shows an upward trend with a 26.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher values indicate significant investment in proprietary technology or market access, though they require monitoring for potential impairment.
Detailed definition
This represents the net value of identifiable intangible assets with a limited useful life, such as patents, licenses, o...
Peer comparison
Common in technology, pharmaceutical, and defense firms that acquire or develop proprietary intellectual property.
non_current_assets_finite_lived_intangible_assets_netHistorical Data
| Q4 '21 | Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.02B | $1.79B | $5.86B | $8.08B | $8.03B | $7.96B | $7.88B | $7.78B | $7.66B | $7.53B | $7.38B | $7.25B |
| QoQ Change | — | -11.8% | +228.0% | +37.9% | -0.6% | -0.9% | -0.9% | -1.4% | -1.5% | -1.8% | -2.0% | -1.7% |
| YoY Change | — | -11.8% | +228.0% | — | — | — | +34.6% | -3.7% | -4.5% | -5.4% | -6.4% | -6.7% |
Intangible assets — net at Other Companies
Frequently Asked Questions
- What is Biogen's intangible assets — net?
- Biogen (BIIB) reported intangible assets — net of $7.25B in Q1 2026.
- How has Biogen's intangible assets — net changed year-over-year?
- Biogen's intangible assets — net decreased by 6.7% year-over-year, from $7.78B to $7.25B.
- What is the long-term trend for Biogen's intangible assets — net?
- Over 5 years (2020 to 2025), Biogen's intangible assets — net has grown at a 26.7% compound annual growth rate (CAGR), from $2.26B to $7.38B.
- What does intangible assets — net mean?
- The value of non-physical assets with a limited lifespan, like patents or licenses.